White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of AT132 Gene Therapy for Patients with X-Linked Myotubular Myopathy

Not recruiting

4 1 1
Investigated drugs:
- Resamirigene Bilparvovec
Study on the Safety and Effectiveness of RTP-026 for Patients with ST-Elevation Myocardial Infarction (STEMI)

Not recruiting

2 1
Investigated diseases:
- Acute myocardial infarction
Investigated drugs:
- Rtp-026 Sodium
Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

Not recruiting

2 1 1 1
Investigated diseases:
- Soft tissue sarcoma
Investigated drugs:
- Dacarbazine
- Onfekafusp Alfa
Study on the Effects of Atidarsagene Autotemcel for Patients with Late Juvenile Metachromatic Leukodystrophy

Not recruiting

3 1 1 1
Investigated diseases:
- Metachromatic leukodystrophy
Investigated drugs:
- Atidarsagene Autotemcel
Study on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
Long-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks

Not recruiting

3 1 1
Investigated diseases:
- Hereditary angioedema
Investigated drugs:
- Garadacimab
Study on Reducing Protein in Urine for Patients with Chronic Kidney Disease Using Finerenone and Semaglutide

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Finerenone
- Semaglutide
Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Not recruiting

3 1
Investigated diseases:
- Psoriatic arthropathy
Investigated drugs:
- Guselkumab
+5
Study on the Safety and Effectiveness of MK-1200 for Patients with Advanced Solid Tumors

Not recruiting

1 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Mk-1200
Study on the Safety and Tolerance of BI 907828 in Patients with Advanced Dedifferentiated Liposarcoma

Not recruiting

3 1 1
Investigated diseases:
- Dedifferentiated liposarcoma
Investigated drugs:
- (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies